drugset / Trial / NCT03086616
CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)
Phase 1
Completed
6 enrolled
Sabine Mueller, MD, PhD
Pacific Pediatric Neuro-Oncology Consortium · collabThe V Foundation for Cancer Research · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase I and Early Efficacy Study of Convection Enhanced Delivery (CED) of irinotecan liposome injection (nal-IRI) Using Real Time Imaging with Gadolinium in Children with Diffuse Intrinsic Pontine Glioma who have completed focal radiotherapy
Timeline
- Start
- 2017-10-31
- Primary completion
- 2021-10-04
- Completion
- 2021-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 20 mg/ml | Other |
| Subject | Irinotecan | Small molecule | 40 mg/ml | Other |